Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Johnson & Johnson Transaction History

Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P.

$649 Million
Q1 2025

A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 18,982 shares of JNJ stock, worth $2.92 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

18,982

Previous 19,113 0.69%

Holding current value

$2.92 Million

Previous $2.76 Million 13.86%

% of portfolio

0.49%

Previous 0.42%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$142.06 - $167.7 $18,609 - $21,968	-131 Reduced 0.69%	18,982 $3.15 Million
Q4 2024 Feb 14, 2025	SELL	$143.34 - $165.86 $30,674 - $35,494	-214 Reduced 1.11%	19,113 $2.76 Million
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $14,257 - $16,403	-98 Reduced 0.5%	19,327 $3.13 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $4,764 - $5,206	-33 Reduced 0.17%	19,425 $2.84 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $28,715 - $30,106	-185 Reduced 0.94%	19,458 $3.08 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $45,281 - $49,411	311 Added 1.61%	19,643 $3.08 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $17,750 - $19,102	115 Added 0.6%	19,332 $3.2 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $33,835 - $40,378	-224 Reduced 1.15%	19,217 $2.98 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $127,198 - $142,753	-794 Reduced 3.92%	19,441 $3.43 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $12,099 - $13,464	-75 Reduced 0.37%	20,235 $3.31 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $238,157 - $263,390	-1,416 Reduced 6.52%	20,310 $3.61 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $131,256 - $149,059	-830 Reduced 3.68%	21,726 $3.85 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $48,182 - $53,460	-309 Reduced 1.35%	22,556 $3.86 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $30,523 - $33,919	189 Added 0.83%	22,865 $3.69 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $10,366 - $11,119	65 Added 0.29%	22,676 $3.74 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $186,898 - $208,156	1,221 Added 5.71%	22,611 $3.72 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $28,793 - $33,049	210 Added 0.99%	21,390 $3.37 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $69,488 - $76,145	-495 Reduced 2.28%	21,180 $3.15 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $42,507 - $51,318	330 Added 1.55%	21,675 $3.05 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $23,450 - $32,491	-211 Reduced 0.98%	21,345 $2.8 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $13,387 - $15,376	-105 Reduced 0.48%	21,556 $3.14 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $6,347 - $7,106	-50 Reduced 0.23%	21,661 $2.8 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $13,115 - $14,424	-100 Reduced 0.46%	21,711 $3.02 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $243,268 - $270,493	-1,935 Reduced 8.15%	21,811 $3.05 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $3,685 - $4,435	-30 Reduced 0.13%	23,746 $3.06 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $122,674 - $144,165	-1,009 Reduced 4.07%	23,776 $3.29 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $52,536 - $57,974	-440 Reduced 1.74%	24,785 $3.01 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $21,892 - $25,924	175 Added 0.7%	25,225 $3.23 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $28,868 - $31,596	-220 Reduced 0.87%	25,050 $3.5 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $3.27 Million - $3.42 Million	25,270	25,270 $3.29 Million

Others Institutions Holding JNJ

# of Institutions

4,656

Shares Held

1.73B

Call Options Held

25M

Put Options Held

15.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $402B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. with notifications on news.

Account

Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Johnson & Johnson Transaction History